TargetMAP kinase-activated protein kinase 2(Homo sapiens (Human))
Astrazeneca R & D Lund
Curated by ChEMBL
Astrazeneca R & D Lund
Curated by ChEMBL
Affinity DataIC50: 1.40E+4nMAssay Description:Inhibition of MK2 assessed as inhibition of [33P]ATP incorporation in to substrate after 30 mins by scintillation countingMore data for this Ligand-Target Pair